Fabiola Terzi

City:

Paris

Country:

France

Published Applications:

Last publication date:

2023-10-12

Top Assignees for applications by Fabiola Terzi

The entities that hold a legal rights for patent applications filed by inventor Terzi Fabiola:

Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
HOFFMANN-LA ROCHE INC. 2 Little Falls, NJ United States
Institut National de la Sante et de la Recherche Medicale 1 Paris, France
INSERM 1 PARIS, France
Hoffman-La Roche Inc. 1 Little Falls, NJ United States
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 1 Paris, France

Recent patent applications by Terzi Fabiola

Fabiola Terzi from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-10-12

US20230321033A1

Human necessities

THIOPHEN COMPOUNDS FOR USE IN THE TREATMENT OF RENAL FIBROSIS

#2 | 2023-06-01

US20230165853A1

Human necessities

METHOD FOR TREATING CHRONIC KIDNEY DISEASES

#3 | 2022-08-11

US20220252617A1

Physics

Biomarkers of fast progression of chronic kidney disease

#4 | 2018-05-24

US20180143206A1

Physics

CXCL10 AS PREDICTIVE BIOMARKER OF RENAL TRANSPLANT ACUTE REJECTION AND DIAGNOSTIC BIOMARKER OF ANTIBODY-MEDIATED REJECTION (ABMR)

#5 | 2017-11-16

US20170328914A1

Physics

BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE

#6 | 2016-08-25

US20160244764A1

Chemistry; metallurgy

Methods for predicting the progression and treating a chronic kidney disease in a patient

#7 | 2016-05-12

US20160130652A1

Chemistry; metallurgy

USE OF URINARY HIV NUCLEIC ACIDS TO DIAGNOSE AND MONITOR HIV-ASSOCIATED NEPHROPATHY (HIVAN)

#8 | 2015-09-17

US20150258127A1

Human necessities

METHODS FOR PREVENTING ANTIPHOSPHOLIPID SYNDROME (APS)

#9 | 2015-01-15

US20150018383A1

Physics

BIOMARKERS OF RENAL DISORDERS

#10 | 2014-03-20

US20140079769A1

Chemistry; metallurgy

METHODS FOR PREDICTING THE PROGRESSION AND TREATING A CHRONIC KIDNEY DISEASE IN A PATIENT

InventorID:

694419 ⎘